Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRO study
2012-001676-11Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Sep 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of ofatumumab in follicular lymphoma (FL) (2 arms), sponsored by Fondazione Italiana Linfomi. Started Sep 2014; status: completed.
02
Drugs
ofatumumab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on 2012-001676-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001676-11.